Associations of serum thyrotropin concentrations with recurrence and death in differentiated thyroid cancer.
about
Thyroid Hormone Replacement in Patients Following Thyroidectomy for Thyroid CancerRadioiodine Remnant Ablation: A Critical ReviewManaging newly diagnosed thyroid cancerManagement of differentiated thyroid cancer in the presence of resistance to thyroid hormone and TSH-secreting adenomas: a report of four cases and review of the literature2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerLong-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancerNew insights in risk stratification of differentiated thyroid cancer.Changes within the thyroid axis after long-term TSH-suppressive levothyroxine therapy.The clinical features of papillary thyroid cancer in Hashimoto's thyroiditis patients from an area with a high prevalence of Hashimoto's disease.Management of differentiated thyroid carcinoma with bone metastasis: a case report and review of the Chinese literatureDiabetes and thyroid cancer risk in the National Institutes of Health-AARP Diet and Health Study.A Logical levothyroxine dose Individualization: Optimization Approach at discharge from Radioiodine therapy ward and during follow-up in patients of Differentiated Thyroid Carcinoma: Balancing the Risk based strategy and the practical issues and chaTumor size interpretation for predicting cervical lymph node metastasis using a differentiated thyroid cancer risk modelPrognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis.Pediatric papillary thyroid cancer: current management challengesThyroid nodules and differentiated thyroid cancer: update on the Brazilian consensus.Differentiated thyroid cancer-personalized therapies to prevent overtreatment.Loss of sorting nexin 5 stabilizes internalized growth factor receptors to promote thyroid cancer progression.Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.A comprehensive review of regulatory test methods for endocrine adverse health effects.Therapeutic options in papillary thyroid carcinoma: current guidelines and future perspectives.Giant congenital nevus associated with papillary thyroid cancer: the first case report.Follicular cell-derived thyroid cancer.Determinants of successful ablation and complete remission after total thyroidectomy and ¹³¹I therapy of paediatric differentiated thyroid cancer.Therapeutic outcomes of papillary thyroid cancer patients in different risk groups.Thyroid hormone resistance in two patients with papillary thyroid microcarcinoma and their BRAFV600E mutation status.Guidelines for the management of thyroid cancer
P2860
Q26765098-942ABEC5-E8D2-4CF2-A075-13E0625F72F7Q26784202-13B80497-8E11-479E-AE01-5538C19571EDQ26825293-C35F57EA-DDEF-46BA-AFE5-53D3A25E4122Q26862777-04ACE98F-95F0-4CD5-8552-3FAD7561BC74Q30367068-FF8B6267-B02A-4010-BF67-0F806C6D2B3CQ33570297-7DE37544-EE12-4CEF-AB84-BF1E18A480A1Q33889219-C3B34B67-583B-46AA-BA3A-D7EE7D555807Q33915384-86C1BEB5-CB6C-415C-8A6B-52BA221C255FQ34226270-9DEBE4D8-009C-485E-BE5E-816DDDA71D49Q34519007-4EE04652-9E16-47F6-BAE8-8275B6C10650Q34696283-59CEFEBF-4401-41C6-B988-020607CB102CQ35183589-A19C4EC4-7382-45BE-82AF-439D0E76C46AQ37150854-FE26404E-7733-45B7-B449-F4D3FC5952B1Q37187701-92EC5517-6E6B-479E-9C24-94825D25B3FFQ37460181-18FEC418-C7FF-4125-8D55-6A29C0FBD7CCQ37551856-BF998252-9541-4599-B0D1-9D2703BEC13BQ38119437-89792254-E7E7-45B1-BC69-0AED98E0CA2FQ38224994-E60EC4D6-EA37-440B-8302-44EF9571F8D5Q38644201-528DEEF4-3CB2-4B04-8353-1FCE0C70D134Q38716870-11AA13EE-6745-40F3-A86D-9F18C18D5C31Q38724654-0450089B-3ED2-4B33-8097-A5B69C91BBF6Q38844362-1328C5A3-D048-4E4B-A1AC-0D3784BD0330Q44604915-D16BCC94-2376-4A9E-96F9-4C1FD75E6684Q48651339-6FA2BD37-D96A-4056-8B5C-3649331D8CEAQ51016692-59BF88F3-E052-48A4-8DBD-28C39B73EC41Q51026868-D8E47653-7E22-431F-B831-63CF6B52CAD8Q53821838-FC94BB6D-C851-41E8-953A-7B9123FE17E5Q56554243-98CD4BA7-0E86-484B-A400-01DA6C99CCEE
P2860
Associations of serum thyrotropin concentrations with recurrence and death in differentiated thyroid cancer.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Associations of serum thyrotro ...... differentiated thyroid cancer.
@ast
Associations of serum thyrotro ...... differentiated thyroid cancer.
@en
Associations of serum thyrotro ...... differentiated thyroid cancer.
@nl
type
label
Associations of serum thyrotro ...... differentiated thyroid cancer.
@ast
Associations of serum thyrotro ...... differentiated thyroid cancer.
@en
Associations of serum thyrotro ...... differentiated thyroid cancer.
@nl
prefLabel
Associations of serum thyrotro ...... differentiated thyroid cancer.
@ast
Associations of serum thyrotro ...... differentiated thyroid cancer.
@en
Associations of serum thyrotro ...... differentiated thyroid cancer.
@nl
P2093
P356
P1476
Associations of serum thyrotro ...... differentiated thyroid cancer.
@en
P2093
Alberto M Pereira
Eleonora P Corssmit
Guido C Hovens
Job Kievit
Johannes A Romijn
Johannes W A Smit
Marcel P Stokkel
P304
P356
10.1210/JC.2006-2566
P407
P577
2007-04-10T00:00:00Z